Home Earnings The latest Earnings results from the Acasti Pharma Inc. (ACST) show promising...

The latest Earnings results from the Acasti Pharma Inc. (ACST) show promising potential

Acasti Pharma Inc. (NASDAQ: ACST) stock closed up 22.45% to $1.2000 on February 11, 2021. As of the start of the latest trading session, Acasti Pharma Inc. (NASDAQ: ACST) shares have gained 201.54% in the year to date (YTD). Stock performance over the past year has been nearly 71.7% higher. If we look at the shorter duration, its week performance is up 44.08% and 71.93% over the month.

Corporate Info


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


The specialty drug company Acasti Pharma Inc. (NASDAQ: ACST) is a biopharmaceutical innovator with a long history of creating and developing prescription drugs, based upon OM3 fatty acids delivered both free and as bound-to-phospholipid esters from krill oil.

What’s the latest about the Stock?

February 10, 2021, The ACST reported its third-quarter operating and financial results for its fiscal year 2020 ended December 31, 2020.

Based on accepted accounting principles in the United States of America, the consolidated financial statements have been prepared.

The company’s loss for the three months ended December 31, 2020, was $2.0 million, compared to a loss of $6.1 million for the same period last year. It resulted from lower sales and marketing expenses, lower R&D expenses, and lower general and administrative costs.

The net loss for the three-month period ended December 31, 2020, was $3.2 million or $0.03 per share, compared with a $12.1 million loss or $0.14 per share. A decline of $4.7 million in net financial expenses resulted in the three-month reduction to a loss of $1.3 million, whereas net financial expenses of $6.0 million were for the three-month period ended December 31, 2019.

Prior to depreciation, amortization, and stock-based compensation expense, R&D expenses reached $620 thousand for the three months ending December 31, 2020, which was lower than $3.2 million during the same period in 2019. A decline in R&D activities along with a reduction in research contracts and a reduction of the department’s headcount was the major reason for the net decrease.

Before the stock-based compensation charges, General and Administrative expenses came in at $931 thousand for the three-month period ended December 31, 2020, and were reduced by $262 thousand when compared to $1.2 million for the period ended December 31, 2019. The primary cause of this decrease is a drop of $251 thousand largely attributed to the legal and professional fees.

For the three-month period ended December 31, 2020, sales and marketing expenses were $488 thousand, compared to $562 thousand for the three-month period ended December 31, 2019.

The cash and cash equivalents at December 31, 2020, was $26.5 million, compared to $14.2 million on March 31, 2020. At this point, Acasti believes existing cash will fully fund the Company’s operations through at least the next 12 months or at the conclusion of the Company’s strategic evaluation. It is vital to the Company’s continued existence that it creates a successful strategic alternative and generates the cash flows to meet its obligations.

Finally,

In our time, the pharmaceutical industry has never had it so good, and science is providing new insights about the prevention and treatment of diseases previously unknown. If a pharmaceutical company can get approval from authorities for the products, it is certain to make huge profits.

 

 

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Onesmart International Education Group Ltd. (ONE) stock surges during current market. What’s driving it high?

Onesmart International Education Group Ltd. (NASDAQ: ONE) stock gains by 111.86% in the current market trading session. OneSmart International Education is a major Chinese...

LivePerson Inc. (LPSN) stock plunge during pre-market. What’s driving it low?

LivePerson Inc. (NASDAQ: LPSN) stock gained by 0.86% at last close whereas the LPSN stock declines by 9.39% in the pre-market trading session. Through...

The Clorox Company Ltd. (CLX) stock decline during pre-market. Here’s the recent update

The Clorox Company Ltd. (NASDAQ: CLX) stock gained by 0.17% at last close whereas the CLX stock price fell by 11.59% in the pre-market....

IT Tech Packaging Inc. (ITP) stock gains during pre-market. Here’s what’s happening?

IT Tech Packaging Inc. (NASDAQ: ITP) stock gained by 7.53% at last close while the ITP stock price rises by 2.04% in the pre-market...

Why did The9 Limited (NCTY) stock turnaround in the after-hours on Friday?

The9 Limited (NCTY) shares gained 6.87% in after-hours on Friday, July 30, 2021, and closed the weekly trading at $11.98 per share. in the...

OneConnect Financial Technology Inc. (OCFT) stock plunge during current market. Here’s what you should know.

OneConnect Financial Technology Inc. (NASDAQ: OCFT) stock declines by 22.12% in the current market trading. In China, OneConnect is the most popular technology-as-a-service platform...

Invitae Corporation Inc. (NVTA) stock surge during current market. Here’s the update:

Invitae Corporation Inc. (NASDAQ: NVTA) stock gains by 12.35% in the current market trading session. Invitae Corporation is a prominent medical genetics business whose...

LivePerson Inc. (LPSN) stock plunge during pre-market. What’s driving it low?

LivePerson Inc. (NASDAQ: LPSN) stock gained by 0.86% at last close whereas the LPSN stock declines by 9.39% in the pre-market trading session. Through...

Related News

FireEye, Inc. (FEYE) Stock Trends Up After Being Enlisted by Colonial Pipeline After Cyberattack

FireEye, Inc. (FEYE) stock prices were up 5.41% earlier in the trading day on May 10th 2021, bringing the price per share up to...

ChemoCentryx Inc. (CCXI) (NASDAQ:CCXI) stock plunged in the premarket trading session; here’s why

At last check, in the premarket trading session ChemoCentryx Inc. (CCXI) shares plunged by-62.50% to $10.31. CCXI's stock closed the previous session at $27.49....

Moderna Inc. (NASDAQ: MRNA) stock declines during current market. Let’s figure out why?

Moderna Inc. (NASDAQ: MRNA) stock falls by 5.31% in the current market trading after MRNA has announced its financial results for Q1 2021. Moderna...

Alfi inc. (NASDAQ:ALF) stock surged in the current trading session; here’s why

In the current trading session, ALF stock had surged by 8.54% to trade at the price of $3.88 at the time of writing. The...

Why The Petco (WOOF) Stock Has Been Moving Upwards Today?

Stock of Petco Health and Wellness Company (NASDAQ: WOOF) has just started getting traction in pre-hours trades today. With over 1.59 million Petco stock...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam